Home Business Nasdaq Halts KaloBios Pharmaceuticals, Inc.

Nasdaq Halts KaloBios Pharmaceuticals, Inc.

Advertisement Disclosure: When you purchase through our sponsored links, we may earn a commission from our partners. By using this website you agree to our T&Cs.


NEW YORK, Dec. 17, 2015 (GLOBE NEWSWIRE) — The Nasdaq Stock Market® (Nasdaq:NDAQ) announced that trading was halted today in KaloBios Pharmaceuticals, Inc. (Nasdaq:KBIO) at 06:48:07 Eastern Time for “additional information requested” from the company at a last price of $23.59.

Trading will remain halted until KaloBios Pharmaceuticals, Inc. has fully satisfied Nasdaq’s request for additional information.

For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotesSM on the Nasdaq® Web site.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com.

 

NDAQO

 

 

CONTACT: Nasdaq Media Contact:
Peter Gau
+1.212.231.5475
[email protected]
Our Editorial Standards

At ValueWalk, we’re committed to providing accurate, research-backed information. Our editors go above and beyond to ensure our content is trustworthy and transparent.

Editor
Investing

Which Stocks Should You Buy, and Sell, in 2026?

Dave Kovaleski6 months

Also, the 3 sectors that Wall Street analysts are most bullish about. The usual suspects dominated in 2025 as both the Communication Services and Information Technology sectors helped boost the...